Discover key insights from Purple Innovation's Q2 2025 earnings call, including revenue growth, Rejuvenate 2.0 success, and strategies for margin recovery.

The supplies, including pills and implants, have already been paid for by US taxpayers – and will cost another $167,000 to ...